As BioJapan 2025 prepares to open, this concise recap of BioJapan 2024 sets the stage: at PACIFICO Yokohama North, Asia’s largest biotech gathering crystallized Japan’s national drive to harness regenerative medicine and gene therapy for both economic growth and patient impact. With 1,500 companies on site and a projected 22,000 business meetings, the event doubled … Japan’s Bio-Economy push at BioJapan 2024 is extending strong momentum into 2025 Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.